Discovery of Small Colony Variants (SCVs)
=========================================

Pure bacterial cultures are not genetically homogeneous, and their behavior is determined by genomic characteristics, such as a high degree of plasticity. Slow-growing subpopulations of bacteria in pure culture have been described from as early as 1913; reported to emerge in response to diverse environmental pressures, they were termed SCVs because they formed pin-prick-sized colonies when cultured on solid media.[@b1-mbi-8-2015-015],[@b2-mbi-8-2015-015] Initially, SCVs were thought of as morphological variants with a secondary role in infectious disease because of their markedly diminished pathogenicity and impaired production of virulence factors.[@b2-mbi-8-2015-015] Furthermore, it was believed that the *G forms*, as they were referred to, may even constitute an ordinary part of the microbial life cycle.[@b3-mbi-8-2015-015],[@b4-mbi-8-2015-015] It was not for many decades following their initial phenotypic characterization that the pathogenic potential of SCVs was realized and their presence within a microbial community was regarded as more than a laboratory curiousity.[@b5-mbi-8-2015-015],[@b6-mbi-8-2015-015]

Early studies clarified the link between environmental stress and the phenotypic changes that became associated with SCVs, including atypical colony morphology, slow growth rate, lack of pigmentation, reduced hemolytic activity, reduced coagulase activity, reduced carbohydrate utilization, low virulence potential, and elevated antibiotic resistance ([Fig. 1](#f1-mbi-8-2015-015){ref-type="fig"}).[@b7-mbi-8-2015-015]--[@b9-mbi-8-2015-015] Indeed, the growth rate of SCVs has been estimated to be approximately nine times slower than that of the progenitor organisms.[@b10-mbi-8-2015-015] As such, SCVs are now better defined as a microbial subpopulation constituting a naturally occurring, slow-growing but diverse bacterial morphotype.[@b7-mbi-8-2015-015],[@b11-mbi-8-2015-015] Clinically, this is problematic; the presence of SCVs during infection is correlated with recurrent or chronic infectious disease. A combination of extended incubation time in addition to altered phenotypic and biochemical traits often means that SCVs in patient samples are overlooked by clinical microbiologists utilizing conventional diagnostic tests. This results in the cessation of antimicrobial treatment before SCVs are effectively cleared from an infection; therefore, they persist causing recurrent and chronic infection.[@b7-mbi-8-2015-015],[@b12-mbi-8-2015-015]

Various environmental stimuli appear to result in phenotypically distinct varieties of SCV.[@b7-mbi-8-2015-015],[@b13-mbi-8-2015-015] Some undergo permanent genetic changes, whereas a subpopulation reverts to a wild-type (WT) phenotype or to a different phenotype that is distinct from both the progenitor and the SCV upon repeated subculture (revertant phenotype) ([Fig. 1](#f1-mbi-8-2015-015){ref-type="fig"}).[@b14-mbi-8-2015-015] Phenotypic reversion, where genetic mutations have not occurred, happens rapidly and circumvents any permanent fitness costs.[@b14-mbi-8-2015-015] The tendency to permanent genetic alteration as compared to phenotypic reversion seems to depend largely on the nature of the original environmental pressure.[@b7-mbi-8-2015-015] There is not always commonality between phenotypic and genotypic changes within different SCV populations, but there are a number of prevalent auxotrophies, characterized initially in *Staphylococcus* spp., including hemin, thiamine, menadione, thymidine, or unsaturated fatty acids.[@b7-mbi-8-2015-015],[@b14-mbi-8-2015-015]--[@b17-mbi-8-2015-015] Conversely, some SCVs do not demonstrate these auxotrophies,[@b18-mbi-8-2015-015]--[@b21-mbi-8-2015-015] for example, those of *Staphylococcus aureus*, selected by Triclosan™ treatment, which revert neither upon supplementation with growth factors nor by repeated subculture.[@b22-mbi-8-2015-015],[@b23-mbi-8-2015-015] The reasons why SCVs are phenotypically diverse remain unclear beyond an unproven link to certain environmental contraints.[@b7-mbi-8-2015-015],[@b24-mbi-8-2015-015],[@b25-mbi-8-2015-015]

Unique Phenotypic Traits Associated with SCVs
=============================================

In addition to the auxotrophies described above, there are a number of other phenotypic characteristics typically associated with SCVs that likely contribute to their ability to persist under adverse growth conditions. One such conventional SCV attribute is diminished electron transport, observed in various species of *Staphylococcus*, *Enterococcus*, and *Pseudomonas*. This phenotype arises as a consequence of mutations impairing the function of menadione, hemin, and thiamine, all of which are required for the biosynthesis of components of the electron transport chain ([Table 1](#t1-mbi-8-2015-015){ref-type="table"}).[@b7-mbi-8-2015-015],[@b14-mbi-8-2015-015]--[@b16-mbi-8-2015-015],[@b26-mbi-8-2015-015],[@b27-mbi-8-2015-015] Ordinarily, menadione is isoprenylated to form menaquinone, the acceptor of electrons from nicotinamide adenine dinucleotide (NADH)/flavin adenine dinucleotide (FADH2) in the electron transport chain, which does not occur in some SCVs.[@b10-mbi-8-2015-015],[@b28-mbi-8-2015-015],[@b29-mbi-8-2015-015] Subsequent reduced electron transport results in a decreased electrochemical gradient and therefore reduced synthesis of adenosine triphosphate (ATP). Large amounts of ATP are required for cell wall biosynthesis, and electron transport is directly linked to the biosynthesis of carotenoid pigments, rendering many SCVs of pigmented species colorless.

The unique cell wall structure of SCVs is believed to confer some degree of protection from stress and is allied with aberrant electron transport. Abnormal cell division has been described for SCVs of *S. aureus*, causing inappropriate cell wall biosynthesis and growth of unusually large cells.[@b21-mbi-8-2015-015],[@b30-mbi-8-2015-015]--[@b32-mbi-8-2015-015] SCVs of *S. aureus* remain to be some of the best characterized, and when examined by electron microscopy are revealed to be a heterogeneous population of differing size, including "empty" cells and substantial amounts of debris.[@b29-mbi-8-2015-015],[@b30-mbi-8-2015-015],[@b33-mbi-8-2015-015] Moreover, while WT *S. aureus* are spherical, with thin cell walls and a relatively uniform cytoplasm,[@b34-mbi-8-2015-015],[@b35-mbi-8-2015-015] their SCV counterparts tend to exhibit much thicker cell walls with irregular cytoplasm of dense granular appearance at the periphery and fine granular materials at the center.[@b34-mbi-8-2015-015] Additionally, SCVs with incomplete, branched, or multiple cross walls without regular cell separation are often also observed.[@b7-mbi-8-2015-015],[@b29-mbi-8-2015-015],[@b30-mbi-8-2015-015] Ghost or empty cells (as mentioned above and observed also for *Enterococcus* spp.) devoid of cytoplasmic content and chromosomal or plasmid DNA and with defective cell walls have also been documented; these are categorized as SCVs despite not being viable microorganisms.[@b30-mbi-8-2015-015]--[@b35-mbi-8-2015-015]

Characteristically, in addition to the aforementioned phenotypic changes, the small regulatory RNA molecule, RNAIII, is usually absent from SCVs and has been particularly well defined for SCVs of *S. aureus*.[@b13-mbi-8-2015-015],[@b36-mbi-8-2015-015],[@b37-mbi-8-2015-015] RNAIII is known to regulate virulence factors, including exoproteins, and cell wall-associated proteins, including adhesins, as well as act as the effector of *agr*-mediated quorum sensing. RNAIII positively regulates the production of toxins and proteases but negatively regulates adhesins, meaning that SCVs tend to be less toxigenic and more prone to adhesion to biotic or abiotic surfaces with enhanced intracellular persistence.[@b38-mbi-8-2015-015],[@b39-mbi-8-2015-015] Virulence during infection is reliant on initial colonization of the host; host--pathogen interactions prevail via bridging mechanisms involving bacterial adhesins and corresponding host proteins.[@b40-mbi-8-2015-015] SCVs adhere to host cells in much the same way as WT microorganisms; the major difference is that SCVs express many more surface adhesins, thus favoring interaction with the host.

Once attached to the host cell, SCVs, like their WT counterparts, induce host-cell changes by actin rearrangement, which mediates internalization, effectively hijacking non-phagocytic cells (including endothelial cells, fibroblasts, osteoblasts, and keratinocytes).[@b41-mbi-8-2015-015],[@b42-mbi-8-2015-015] Pathogens that are not categorized as SCVs utilize the same mechanism of internalization, but crucially, SCVs are far more efficient at this process than their progenitors.[@b43-mbi-8-2015-015] Fundamentally, this intracellular protection affords additional defense against immune clearance or antimicrobial treatment. Owing to their reduced toxicity, the uptake of SCVs in this manner occurs in vitro without damage to host cells.[@b44-mbi-8-2015-015] Once inside the host cell, intracellular survival is critical to retain protection.[@b40-mbi-8-2015-015] SCVs characteristically proliferate intracellularly, more successfully than their progenitors, which is a trait that directly contributes to antibiotic treatment failure and poor prognosis in patients.[@b45-mbi-8-2015-015]--[@b47-mbi-8-2015-015] A marked increase in the expression of member genes of the arginine deaminase pathways in SCVs of *S. aureus* results in the reduced function of vital host enzymes involved in the immune response and is believed to be key to successful intracellular persistence.[@b36-mbi-8-2015-015]

In addition, SCVs evade the immune response and persist intracellularly by escaping from intracellular phagosomes,[@b43-mbi-8-2015-015],[@b48-mbi-8-2015-015] thus avoiding the hydrolytic activity of lysosomes.[@b48-mbi-8-2015-015] It has been proposed that unlike other intracellular pathogens, once in the cytoplasm, SCVs may no longer disrupt normal actin polymerization of the cells in which they reside, meaning that they do not elicit normal intracellular cytokine and chemokine defense mechanisms.[@b40-mbi-8-2015-015] Therefore, the ability of SCVs to dampen the proinflammatory response means that the attenuated virulence associated with the SCV phenotype is in fact favorable for their survival and prolonged persistence within the host.[@b46-mbi-8-2015-015] The recovery of SCVs from the cases of asymptomatic infection supports this theory of persistence through diminished host damage.[@b48-mbi-8-2015-015],[@b49-mbi-8-2015-015]

Unique Genotypic Features Associated with SCVs
==============================================

Several genetic mutations can result in the electron transport-defective SCV phenotype described above, including the mutations in *menD*, *hemB*, and *ctaA*.[@b38-mbi-8-2015-015],[@b44-mbi-8-2015-015],[@b50-mbi-8-2015-015],[@b51-mbi-8-2015-015] *MenD* encodes for 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase, which catalyses the conversion of isochorismate 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate. *HemB* encodes for porphobilinogen synthase, which is essential for subsequent porphyrin metabolism.[@b36-mbi-8-2015-015],[@b44-mbi-8-2015-015],[@b52-mbi-8-2015-015]--[@b54-mbi-8-2015-015] *CtaA* encodes haem-O-monooxygenase that converts haem-O to haem-A, which is an essential cofactor for enzymes involved in electron transport,[@b53-mbi-8-2015-015] and its deficiency inhibits cytochrome biosynthesis.[@b7-mbi-8-2015-015] Mutations in *menD* and *hemB* block the biosynthesis of menadione, which is used in menaquinone biosynthesis. Mutations in *menD*, *hemB*, or *ctaA* can also lead to defective cytochrome biosynthesis.[@b7-mbi-8-2015-015] Both *menD* and *hemB* mutations also impair the biosynthesis of cytochromes.[@b36-mbi-8-2015-015],[@b44-mbi-8-2015-015],[@b52-mbi-8-2015-015],[@b53-mbi-8-2015-015]

During infection, organisms are exposed to high levels of haem that may be toxic because of the accumulation of superoxides. By virtue of the mutations described above, haem stress for SCVs is significantly alleviated, suggesting that a reduction in haem-associated stress may be an additional factor enabling the survival of SCVs during chronic infection.[@b54-mbi-8-2015-015] Genes governing other aspects of general metabolic pathways associated with energy production and respiration in SCVs often also carry mutations ([Table 1](#t1-mbi-8-2015-015){ref-type="table"}). They primarily include genes encoding proteins of the Entner--Doudoroff pathway, reconciling the slower growth rate of SCVs that contributes to their persistence.

Increased adhesion and biofilm formation are correlated with the enhanced expression of surface-bound adhesins and their cognate transcriptional regulators.[@b55-mbi-8-2015-015]--[@b58-mbi-8-2015-015] Adhesins not only function as a means of binding directly to host proteins prior to colonization but also enable interbacterial aggregation, which is critical to the development of biofilm; SCVs are characteristically prolific biofilm-forming organisms.[@b59-mbi-8-2015-015] The expression of adhesin genes is often governed by global transcriptional regulators that form part of an intricate transcriptional network that responds to environmental cues, usually involving quorum sensing. Therefore, it is not surprising to find that genes encoding transcriptional regulators, such as *agr*, *sigB*, and *sarA*, are differentially regulated in SCVs of both *Bacillus cereus* and *S. aureus* ([Table 1](#t1-mbi-8-2015-015){ref-type="table"}).[@b60-mbi-8-2015-015]--[@b65-mbi-8-2015-015] Indeed, during chronic infection where the SCV phenotype begins to emerge, the expression of these transcriptional regulators is repressed, thus suppressing virulence gene expression, promoting intracellular survival, and dampening the host immune response ([Table 1](#t1-mbi-8-2015-015){ref-type="table"}).[@b66-mbi-8-2015-015]

Although differentially expressed or mutated genes tend to be conserved in SCVs, to date no defined core set of SCV genes has been documented. Often SCV-associated phenotypic traits are not the result of permanent genetic mutations but may instead result from genome rearrangements; therefore, identifying SCVs at the genotypic level is potentially as challenging as identifying them based on phenotype alone. Moreover, numerous phenotypic traits can be attributed to epigenetics.[@b67-mbi-8-2015-015] Where genetic traits are conserved, they usually confer essential adaptations; transient characteristics that are not an absolute requirement for survival, but which confer a competitive advantage, are likely controlled by uncharacterized global transcriptional regulators or alternative sigma factors ([Table 1](#t1-mbi-8-2015-015){ref-type="table"}) that form part of a larger and as yet undefined *SCV regulon*. Since only traits that are conferred by permanent genetic change are heritable, the maintenance of a stable SCV community within the larger microbial consortia is postulated to depend on appropriate regulatory signals. Significantly, DNA mismatch repair systems are often impaired in SCVs, leading to the accumulation of genetic mutations that confer the typical SCV phenotype or, in some cases, result in hypermutability and alternative variant phenotypes.[@b68-mbi-8-2015-015]

SCVs within Microbial Communities
=================================

Variants occur at random within microbial populations; most are transitory with only those changes that allow bacteria to remain viable and confer an advantage becoming fixed within a population. Microbial adaptation to a particular environment and competition between the members of a heterogeneous population, comprising a parent (wild type) and progeny (including mutants), are dictated by growth parameters and stresses.[@b69-mbi-8-2015-015] Numerous laboratory studies have demonstrated that successful microorganisms, namely, those that succeed within a given environment, do so because they exhibit the highest growth rate under prevailing conditions.[@b70-mbi-8-2015-015] Despite this, SCVs persist within microbial communities, albeit as a minor constituent that is never entirely outcompeted by the parental strain. Given the tenacity of SCVs to survive under stress, it might be expected that they should eventually predominate. Certainly with regard to antimicrobial interventions,[@b71-mbi-8-2015-015] this is the case, as the more susceptible parent strain is eradicated leaving behind a population of SCVs that can undergo reversion, which results in a recurrence of infection ([Fig. 2](#f2-mbi-8-2015-015){ref-type="fig"}).[@b72-mbi-8-2015-015] SCVs that arise during human infection appear better adapted for survival and persistence within the host[@b73-mbi-8-2015-015] despite their impaired rate of growth and increased host dependency. Selection because of loss or redundancy of metabolic activity is not unusual and under certain growth conditions,[@b74-mbi-8-2015-015] such as the host environment, might confer a fitness advantage, if not in terms of growth, in terms of survival.[@b75-mbi-8-2015-015] Many host-adapted and therefore invariably host-dependent pathogens undergo reductive evolution;[@b76-mbi-8-2015-015] driven by the host habitat and their ability to utilize host metabolites, such organisms become slow growing and nutritionally fastidious, often adopting an intracellular lifestyle.[@b77-mbi-8-2015-015] This process is ordinarily mediated by the loss of large fragments of genomic DNA. SCVs appear similar to host-adapted pathogens, and the loss of metabolic function renders them reliant on the host to meet their nutritional needs;[@b78-mbi-8-2015-015] indeed, many SCVs survive intracellularly. Where reductive evolution occurs in pathogens, it is correlated with increased virulence[@b79-mbi-8-2015-015] that is not observed for SCVs, which conversely seem to exhibit attenuated virulence.[@b80-mbi-8-2015-015] Significantly, pathogens that undergo reductive evolution do not regain "lost" genetic function[@b81-mbi-8-2015-015] unlike SCVs that are able to revert to WT or WT like once selective pressures, such as antimicrobial treatment, are removed ([Figs. 1](#f1-mbi-8-2015-015){ref-type="fig"} and [2](#f2-mbi-8-2015-015){ref-type="fig"}). Therefore, for SCVs, there is apparently a trade-off between virulence and persistence that exploits the ability to revert to a WT or WT-like variant, which is less host dependent and regains virulence. The specific adaptations that the minority SCV population depends on to ensure survival among their faster growing counterparts include the increased expression of surface adhesins as previously described. If two microorganisms are competing for the same human receptor, then those with a binding advantage (ie, more surface adhesins) are more likely to adhere.[@b82-mbi-8-2015-015],[@b83-mbi-8-2015-015] Combined with enhanced biofilm formation, such colonizers are less likely to be removed from the host by detachment.[@b84-mbi-8-2015-015] Intracellular survival provides more than simple protection from immunity, with the cell cytoplasm providing a nutritionally rich habitat for auxotrophic SCVs that is not afforded to the parental strain, but at the same time reduces competition for space at the tissue surface.[@b85-mbi-8-2015-015] It is proposed that in this way, both SCV and progenitor can coexist.

SCVs in Chronic Infection
=========================

SCVs show enhanced resistance to a range of antibiotics[@b7-mbi-8-2015-015],[@b25-mbi-8-2015-015],[@b86-mbi-8-2015-015]--[@b88-mbi-8-2015-015] and have been directly associated with persistent infections in a number of diseases, including, but not limited to, cystic fibrosis,[@b89-mbi-8-2015-015],[@b90-mbi-8-2015-015] chronic obstructive pulmonary disease,[@b91-mbi-8-2015-015] diabetic foot ulcers,[@b92-mbi-8-2015-015] chronic rhinosinusitis,[@b93-mbi-8-2015-015] chronic wound infections,[@b94-mbi-8-2015-015]--[@b96-mbi-8-2015-015] systemic infections,[@b97-mbi-8-2015-015] and infections arising from surgical intervention or medical devices,[@b98-mbi-8-2015-015]--[@b102-mbi-8-2015-015] which can lead to serious and sometimes fatal clinical consequences, such as endocarditis, bacteremia, or meningitis.[@b97-mbi-8-2015-015],[@b102-mbi-8-2015-015] It has been proposed that in the case of the ventriculoperitoneal shunt (a medical device used in the treatment of hydrocephalus), SCV-associated meningitis infection can arise from inadequate disinfection of the shunt and failure to identify and treat these persistent variants.[@b103-mbi-8-2015-015] Chronic infections represent a significant burden to both patients and health-care providers. Where chronicity ensues, biofilm is frequently present.[@b104-mbi-8-2015-015]--[@b108-mbi-8-2015-015] The presence of SCVs within biofilms has been directly linked to chronic antibiotic-resistant infections, including cystic fibrosis in lung, osteomyelitis, catheter and pacemaker infection, among others as previously described.[@b87-mbi-8-2015-015]--[@b93-mbi-8-2015-015],[@b108-mbi-8-2015-015]--[@b115-mbi-8-2015-015] The respiratory tract of cystic fibrosis patients provides a unique environment for the selection of a subgroup of autoaggregative and highly adherent SCVs of *Pseudomonas aeruginosa*.[@b20-mbi-8-2015-015],[@b115-mbi-8-2015-015],[@b116-mbi-8-2015-015] These SCVs are hyperpiliated and exhibit increased twitching motility as well as have the capacity to emerge and successfully endure in biofilms, thus contributing significantly to the pathogenesis of *P. aeruginosa* lung infection.[@b115-mbi-8-2015-015],[@b116-mbi-8-2015-015] However, it is the hyperaggregative property of these SCVs that is the primary contributing factor to etiology of chronic infection because it enables microorganisms to produce large amounts of polysaccharide intercellular adhesion and highly structured biofilms.[@b117-mbi-8-2015-015] Significantly, a recent study describing polymicrobial biofilm comprising *P. aeruginosa* and *S. aureus* suggests that the cohabitation of these microorganisms not only leads to a more dense and stable biofilm formation but also induces SCV emergence, even in the absence of antibiotics.[@b83-mbi-8-2015-015] Specifically, SCV of *S. aureus* emerged following the exposure to 4-hydroxy-2-heptylquinoline-N-oxide, secreted by *P. aeruginosa,* which is known to impair the growth of *S. aureus*. Growth impairment was attributed to a shift to the slower growing SCV morphotype.[@b118-mbi-8-2015-015] This phenomenon has been best studied in cocultured organisms derived from patients with cystic fibrosis who present with chronic infection for which antibiotic treatment is received, where SCVs of *S. aureus* were identified in 24% of the patients.[@b119-mbi-8-2015-015] It is believed that for *S. aureus*, this is a specific survival strategy in the presence of *P. aeruginosa*, mediating protection from secreted exotoxin A, which targets the electron transport chain.[@b25-mbi-8-2015-015]

The rate of occurrence of SCVs in chronic infection is likely to vary depending on the clinical conditions;[@b7-mbi-8-2015-015] nonetheless, SCVs are detected in approximately 1% of isolates in a clinical microbiology laboratory and their incidence is the highest in cystic fibrosis and osteomyelitis.[@b7-mbi-8-2015-015] It is pertinent to highlight that in patients with osteomyelitis, surgical placement of slow-release gentamicin beads along with debridement is a common practice for treatment and may be linked to SCV induction.[@b120-mbi-8-2015-015] This is of concern as inadvertent iatrogenic-induced SCVs may be formed as a result of the long-term exposure to gentamicin; studies have verified that SCVs can be recovered from patients undergoing treatment with gentamicin beads.[@b120-mbi-8-2015-015] It has consequently been suggested that routine screening for SCVs should take place for patients treated with gentamicin beads for osteomyelitis.[@b28-mbi-8-2015-015] Furthermore, given the recalcitrance of SCV-associated infection, it might seem reasonable to screen persons who are predisposed to developing chronic infection following the completion of antimicrobial chemotherapy. Therefore, with regard to efficacious antimicrobial treatments, the identification of SCVs is as important as ensuring an appropriate dose of antimicrobial is administered. However, this approach is confounded by the relatively limited information describing successful treatment of SCV infections. Since aminoglycosides are known to promote the emergence of SCVs in some bacterial species, including *P. aeruginosa*, they are unlikely to constitute a suitable treatment where such SCVs persist. Vancomycin exhibits a higher degree of efficacy against SCVs than most antibiotics, but its potency is estimated to be approximately half of that typically observed for the treatment of non-SCV organisms.[@b121-mbi-8-2015-015] It is possible to achieve bactericidal activity against *S. aureus hemB* mutants using daptomycin, and the effect is concentration dependent, suggesting that at its simplest, SCVs can be effectively treated using higher doses of antibiotics that are normally prescribed to treat infection.[@b122-mbi-8-2015-015] However, until satisfactory laboratory isolation is achieved, SCVs will remain very difficult to detect in patient samples and will, therefore, remain excluded from the standard antimicrobial testing regimens.

Future Perspectives
===================

Although SCVs have been known to exist for over century, little attention was originally given to them as they were believed to be nonvirulent and therefore not clinically important. However, as more is understood about their role in persistent infections, it has become imperative that mechanisms of SCV persistence and resistance, as well as population dynamics, are thoroughly explored. Recent investigations have proposed a low-cost point-of-care test for the diagnosis of *P. aeruginosa* in patients at risk of chronic respiratory infection for rapid and economical diagnosis. This method, named electrochemical impedance spectroscopy, has successfully differentiated strains of *P. aeruginosa* based on their impedance signature, which is influenced by factors such as pyocyanin secretion.[@b123-mbi-8-2015-015] While this method has not yet been tested using the SCVs of *P. aeruginosa*, many SCVs exhibit differential pyocyanin production and so could be potentially identified via this means that could replace traditional culture methods. With this in mind, it seems reasonable to suggest that accurate diagnosis of SCV-associated infections will rely on nontraditional diagnostics, including the use of molecular probes, in future. The principle complication for the development of such diagnostic methodology is the varied phenotypic and genotypic traits exhibited by SCVs; without a core set of SCV genes even with new diagnostic techniques, it might prove as easy to misdiagnose SCVs in infection as by traditional culture.
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![WT organisms undergo a shift to the SCV phenotype under the conditions of stress, where they exhibit a slower growth rate but increased antibiotic resistance. They can revert to a WT-like (indicated by a dashed line to denote that WT-like organisms are not identical to the original WT progenitor) or alternative revertant (R) phenotype when the environmental stress is removed, regaining a faster growth rate but becoming more susceptible to antibiotic treatment.](mbi-8-2015-015f1){#f1-mbi-8-2015-015}

![Pure populations of bacteria often comprise WT (major population; blue) and SCV (minor population; orange), which arise spontaneously; under environmental stress, such as antibiotic treatment, the WT population is diminished and SCVs survive; under sustained stress, such as a course of antibiotics to treat an infection, the SCVs become the dominant members of the population. When the selective pressure is removed, WT organisms proliferate and become the dominant members of the population compared to slow-growing SCVs; significantly a proportion of SCVs revert to either the WT phenotype or a WT-like phenotype (green), which regains characteristics that enable faster growth.](mbi-8-2015-015f2){#f2-mbi-8-2015-015}

###### 

Characteristics associated with SCVs.

  GENE                                             PROTEIN                                                         FUNCTION                                                                                               VARIATION                                                                                                           EXAMPLE ORGANISM(S)                                                                             SELECTED REFERENCES
  ------------------------------------------------ --------------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------
  **Altered interaction with the host**                                                                                                                                                                                                                                                                                                                                                                                                       
  *clfA*                                           Clumping Factor A                                               Fibrinogen binding                                                                                     Increased expression in *hemB* background                                                                           *Staphylococcus* spp.                                                                           [@b57-mbi-8-2015-015]
  *fnb*                                            Fibronectin Binding Protein                                     Fibronectin binding                                                                                    Increased expression in *hemB* background                                                                           [@b57-mbi-8-2015-015]                                                                           
  *spa*                                            Protein A                                                       Surface protein, inhibits phagocytosis                                                                 Transcription reduced in SCV: avoidance of host immunity                                                            [@b57-mbi-8-2015-015]                                                                           
  **Altered biosynthesis or enzymatic pathways**                                                                                                                                                                                                                                                                                                                                                                                              
  *hemL*                                           Glutamate 1-semi-aldehyde aminotransferase                      Porphyrin biosynthesis                                                                                 Gene interruption causing persistent infection                                                                      *Staphylococcus* spp. *Pseudomonas aeruginosa*                                                  [@b52-mbi-8-2015-015]
  *hemB*                                           Porphobilinogen synthase                                        Porphyrin biosynthesis                                                                                 Gene interruption causing persistent infection                                                                      *Escherichia coli Salmonella enterica* sv. Typhimurium *Enterococcus* spp.                      [@b52-mbi-8-2015-015]
  *menD*                                           2-succinyl-6-hydroxy-2,4-cyclohexadine-1-carboxylate synthase   Cytochrome biosynthesis                                                                                Gene interruption causing persistent infection                                                                      *Staphylococcus* spp. *Pseudomonas aeruginosa Enterococcus* spp.                                [@b7-mbi-8-2015-015]
  *ctaB*                                           Haem-O-monooxygenase                                            Cytochrome biosynthesis                                                                                Gene interruption causing persistent infection                                                                      *Staphylococcus aureus*                                                                         [@b7-mbi-8-2015-015], [@b39-mbi-8-2015-015]
  *citB*                                           Aconitase                                                       Catalyses isomerization of citrate to isocitrate in the tricarboxylic acid cycle                       Down-regulated in *hemB* background                                                                                 *Staphylococcus* spp.                                                                           [@b13-mbi-8-2015-015]
  *aroD*                                           5-dehydroquinate hydrolyase                                     Menadione biosynthesis                                                                                 Defective in SCV: increased persistence                                                                             *Staphylococcus* spp. *Salmonella enterica* sv. Typhimurium                                     [@b26-mbi-8-2015-015]
  *ldh*                                            Lactate dehydrogenase                                           Converts pyruvate to lactate in hypoxic/anoxic conditions                                              Defective in SCV: increased persistence                                                                             *Staphylococcus* spp.                                                                           [@b26-mbi-8-2015-015]
  *thyA*                                           Thymidylate synthase                                            Catalyses the conversion of deoxyuridine monophosphate (dUMP) to deoxythymydine monophosphate (dTMP)   Varied mutations resulting in thymidine auxotrophy                                                                  *Stenotrophomonas maltophilia Staphylococcus aureus Pseudomonas aeruginosa Enterococcus* spp.   [@b13-mbi-8-2015-015], [@b14-mbi-8-2015-015]
  **Transcriptional regulation**                                                                                                                                                                                                                                                                                                                                                                                                              
  *agr*                                            Accessory gene regulator                                        Global virulence regulator--- quorum sensing                                                           Impaired expression in SCV: chronicity                                                                              *Staphylococcus aureus*                                                                         [@b38-mbi-8-2015-015], [@b39-mbi-8-2015-015]
  *sarA*                                           Accessory gene regulator                                        Global virulence regulator--- biofilm formation                                                        Impaired expression in SCV: chronicity                                                                              *Staphylococcus aureus*                                                                         [@b60-mbi-8-2015-015], [@b62-mbi-8-2015-015]
  *sigB*                                           Alternative stress regulator                                    Alternative stress regulator---intracellular persistence                                               Down-regulated or silenced in SCV: increased intracellular persistence and resistance to hydrogen peroxide stress   *Bacillus cereus Staphylococcus aureus*                                                         [@b58-mbi-8-2015-015], [@b59-mbi-8-2015-015], [@b61-mbi-8-2015-015], [@b63-mbi-8-2015-015]
  **Miscellaneous function**                                                                                                                                                                                                                                                                                                                                                                                                                  
  *mutL*                                           Member of MutHLS complex                                        Methyl-directed mismatch repair (MMR) system                                                           Gene truncated due to frameshift mutations in thymidine-dependent SCV isolates: hypermutability                     *Pseudomonas aeruginosa*                                                                        [@b65-mbi-8-2015-015]
  *nupC*                                           Nucleoside permease                                             High affinity nucleoside transporter                                                                   Gene mutations in thymidine-dependent SCVs                                                                          *Stenotrophomonas maltophilia Staphylococcus aureus*                                            [@b7-mbi-8-2015-015]
  *hla*                                            α-hemolysin                                                     Initiates eukaryotic cell apoptosis and necrosis                                                       Expression impaired in SCV: attenuated virulence and enhanced intracellular persistence                             *Staphylococcus aureus*                                                                         [@b7-mbi-8-2015-015]
